When It Comes To Antibody Technology, Pfizer's On The Prowl
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer's latest partnership in the space is with Theraclone Sciences, a Seattle start-up with an antibody technology that uses human B cells.